Molecular diagnostic instrument
24 Oct 2025Getting your new molecular diagnostic (MDx) product to market quickly matters not only to you and your shareholders, but to the physicians and patients who need it.
A new technology company approached Plexus with a high investment hurdle - to launch and distribute a new MDx instrument for rapid bacterial detection, identification and antimicrobial susceptibility testing. This case study showcases how Plexus was able to minimize design and development delays, increase collaboration and help bring a new IVD technology to market.
Related products
Request Quote for All Products
Design & Development
PlexusWe partner with you to turn complex concepts into commercially viable life science instruments. Our teams integrate regulatory strategy, DfX optimization, and rigorous testing from day one, ensuring your product is compliant, reliable, and optimized for global scale, accelerating your path to market.
New Product Introduction
PlexusNPI is your bridge from final design to high-volume manufacturing. We ensure manufacturing readiness and scalable production through Design for Excellence (DfX) and expert program leadership. We manage rapid prototyping, supply chain build-out, and tailored testing to mitigate launch risks and accelerate time-to-market.
Supply Chain Solutions
PlexusWe build resilient, cost-effective supply chains for your long-lifecycle products. Through early engagement during design, we mitigate risk, plan for component obsolescence, and ensure a consistent flow of materials. This shields your production schedule from global market volatility and guarantees program sustainment.